We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Pathology

Image: A histopathology micrograph of anaplastic thyroid carcinoma (Photo courtesy of The Clayman Thyroid Cancer Center).

Thyroid Cancer Genetics Study Finds New Mutations

Anaplastic thyroid cancer (ATC) is a form of thyroid cancer, which has a very poor prognosis due to its aggressive behavior and resistance to cancer treatments. Its anaplastic cells have poor differentiation, including dedifferentiation. More...
08 May 2018
Image: A diagram of breast cancer detection using artificial neural network (Photo courtesy of Ben-Gurion University).

Breath and Urine Tests Detect Early Breast Cancer

Breast cancer is the most commonly diagnosed malignancy among females and the leading cause of death around the world. In 2016, breast cancer accounted for 29% of all new cancers identified in the USA and was responsible for 14% all cancer-related deaths. More...
08 May 2018
Image: The nanoLC-Ultra 1D+ for nanoflow liquid chromatography (Photo courtesy of Eksigent).

Biomarkers Identified for Irritable Bowel Syndrome

The causes of gastrointestinal complaints in irritable bowel syndrome (IBS) remain poorly understood. Altered nerve function has emerged as an important pathogenic factor as IBS mucosal biopsy supernatants consistently activate enteric and sensory neurons. More...
02 May 2018
Image: A diagram of the microfluidic device that uses magnetic particles and wavy-herringbone design to capture and release circulating tumor cells (Photo courtesy of Lehigh University).

Cancer Blood Test Engineered to Detect Tumors Early

A new innovative microfluidic device has been developed that uses magnetic particles and wavy-herringbone design to capture and release circulating tumor cells (CTC) with a high capture efficiency rate at different tumor cell concentrations. More...
02 May 2018
Image: The new streamlined approach discovered for diagnosing and treating bowel cancer (Photo courtesy of University of Adelaide).

Streamlined Approach Discovered for Treating Bowel Cancer

More than 4,000 Australians die from bowel cancer each year, and more than 17,000 new cases of this cancer will be diagnosed in 2018. Scientists are working to understand the genetic drivers of bowel cancer, with a special interest in those cancers which are the hardest to treat, and which have the poorest prognosis. More...
02 May 2018
Image: The QX200 AutoDG Droplet Digital PCR System provides absolute quantification of target DNA or RNA molecules for EvaGreen and probe-based ddPCR applications (Photo courtesy of Bio-Rad).

Molecular Technology Identifies Potential Biomarker for Cancer

For patients with early-stage non-small cell lung cancer (NSCLC), the only recommended treatment option is surgery. After complete resection patients with disease at the same stage experience different outcomes, and within five years a third of patients relapse. More...
26 Apr 2018
Image: A histopathology micrograph of a liver biopsy showing of steatohepatitis showing balloon degeneration of hepatocytes, a form of apoptosis (Photo courtesy of Nephron).

Image Analysis System Quantifies NASH Disease Activity

Non-alcoholic steatohepatitis (NASH) is the progressive form of non-alcoholic fatty liver disease (NAFLD), in which excessive fat accumulates in the liver of individuals who do not have a history of alcohol abuse. More...
25 Apr 2018
Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Alcohol Testing Device
Dräger Alcotest 7000


The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.